Pharmacist Selection and Reimbursement:
HB 941 would expand the role of licensed pharmacists in several Florida health coverage arrangements by allowing covered persons to choose an in-network pharmacist for services that are within a pharmacist’s scope of practice. The bill applies this selection right across the state group insurance program, Medicaid managed care and related Medicaid coverage arrangements, individual and group health insurance policies, and health maintenance contracts. It also bars plans from denying reimbursement to an in-network pharmacist when the same service would be covered if provided by a physician, physician assistant, or advanced practice registered nurse.
The bill further provides that licensed pharmacists may count toward network adequacy standards for provider access, but it makes clear that simply including pharmacies in a drug-benefit network is not enough to satisfy that requirement. The act would take effect January 1, 2026, and it creates new statutory sections in multiple chapters of Florida law to implement the same pharmacist-selection and reimbursement framework across public and private coverage systems.
HB 941 would amend Florida insurance and Medicaid statutes by creating parallel provisions in chapters 110, 409, 627, and 641, establishing a uniform rule that in-network pharmacists can be selected and reimbursed for covered services within their lawful scope of practice. It would affect the state employee health plan, Medicaid managed care, Medicaid-related provider arrangements, individual and group health insurance, and HMO contracts. The bill also changes how network adequacy may be measured by allowing pharmacists to count as access providers, which could influence insurer and managed care network design, credentialing, and reimbursement policies.
The available legislative history shows no recorded committee transcript or vote data, and the bill ultimately died in the Health Care Facilities & Systems Subcommittee. Based on the text, the measure appears to be a pro-pharmacist access and reimbursement bill intended to broaden patient choice and recognize pharmacists as accessible providers for certain covered services. The lack of recorded debate makes it difficult to identify a detailed consensus, but the bill’s failure to advance suggests it did not secure sufficient support in committee.
The main points of contention likely center on whether pharmacists should be treated as reimbursable service providers on par with physicians, physician assistants, and advanced practice registered nurses for covered services, and whether this expansion could increase costs or complicate network and utilization management for insurers and Medicaid plans. Another potential issue is the network adequacy provision, which may be viewed by insurers as a significant regulatory change because it requires pharmacists themselves—not just pharmacies in drug networks—to count toward access standards. No specific opposing arguments are recorded in the provided materials, but these are the most likely areas of dispute.